Skip to main content

ORIGINAL RESEARCH article

Front. Med., 19 July 2021
Sec. Infectious Diseases – Surveillance, Prevention and Treatment
Volume 8 - 2021 | https://doi.org/10.3389/fmed.2021.668698

RETRACTED: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

John McCoy1* Andy Goren1 Flávio Adsuara Cadegiani1,2 Sergio Vaño-Galván3 Maja Kovacevic4 Mirna Situm4 Jerry Shapiro5 Rodney Sinclair6 Antonella Tosti7 Andrija Stanimirovic8 Daniel Fonseca9 Edinete Dorner9 Dirce Costa Onety9 Ricardo Ariel Zimerman10 Carlos Gustavo Wambier11
  • 1Applied Biology, Inc. Irvine, CA, United States
  • 2Department of Endocrinology, Corpometria Institute, Brasilia, Brazil
  • 3Dermatology Department, Ramón y Cajal Hospital, Madrid, Spain
  • 4Department of Dermatology and Venereology, University Hospital Center “Sestre Milosrdnice”, Zagreb, Croatia
  • 5Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, United States
  • 6Sinclair Dermatology, Melbourne, VIC, Australia
  • 7Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, United States
  • 8School of Medicine, European University Cyprus, Nicosia, Cyprus
  • 9Intensive Care Unit, Samel Hospital, Manaus, Brazil
  • 10Hospital da Brigada Militar, Porto Alegre, Brazil
  • 11Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, United States

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: McCoy J, Goren A, Cadegiani FA, Vaño-Galván S, Kovacevic M, Situm M, Shapiro J, Sinclair R, Tosti A, Stanimirovic A, Fonseca D, Dorner E, Onety DC, Zimerman RA and Wambier CG (2021) Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial. Front. Med. 8:668698. doi: 10.3389/fmed.2021.668698

Received: 17 February 2021; Accepted: 11 June 2021;
Published: 19 July 2021; Retracted: 10 June 2022.

Edited by:

Zisis Kozlakidis, International Agency For Research on Cancer (IARC), France

Reviewed by:

Chao Ren, First Hospital Affiliated to the Chinese PLA General Hospital, China
Olufemi Babalola, ECWA Bingham University, Nigeria
Download